Two Major Liver Threats—And Why Scientists Are Hopeful About Fighting Back

Scientists have discovered exactly how high-fat diets transform healthy liver cells into cancer-prone cells, and they've identified promising drug targets that could prevent this deadly progression. A groundbreaking MIT study reveals that fatty diets force liver cells to revert to an immature, stem-cell-like state that makes them significantly more susceptible to becoming cancerous.

How Does a High-Fat Diet Actually Damage Your Liver?

Researchers fed mice high-fat diets and used advanced genetic sequencing to track what happened inside their liver cells over time. What they found was alarming: the liver cells began prioritizing their own survival over their normal functions. "This really looks like a trade-off, prioritizing what's good for the individual cell to stay alive in a stressful environment, at the expense of what the collective tissue should be doing," explains Constantine Tzouanas, MIT graduate student and co-first author of the study.

The liver cells made several dangerous changes to survive the fatty environment:

• Resistance Building: Cells became more resistant to natural cell death and more likely to multiply uncontrollably
• Function Loss: Cells stopped producing critical metabolic enzymes and proteins the liver needs to work properly
• Immaturity Reversion: Cells reverted to a stem-cell-like state that made them prime targets for cancer-causing mutations

Nearly all mice on the high-fat diet developed liver cancer by the end of the study, demonstrating the direct link between dietary fat and liver cancer risk.

What Makes These Cellular Changes So Dangerous?

When liver cells revert to an immature state, they essentially get a "head start" on becoming cancerous. "These cells have already turned on the same genes that they're going to need to become cancerous. They've already shifted away from the mature identity that would otherwise drag down their ability to proliferate," Tzouanas explains. "Once a cell picks up the wrong mutation, then it's really off to the races and they've already gotten a head start on some of those hallmarks of cancer."

This study used single-cell ribonucleic acid (RNA) sequencing to monitor gene expression changes as mice progressed from liver inflammation to tissue scarring and eventually cancer. The researchers discovered that some cellular changes happened immediately, while others, like the decline in metabolic enzyme production, shifted gradually over longer periods.

Why Are Scientists Hopeful About Fighting Back?

The MIT team identified several genes that orchestrate these dangerous changes, and remarkably, some are already being targeted by drugs in development. The researchers found that a drug targeting thyroid hormone receptor was recently approved to treat a severe form of steatotic liver disease called MASH fibrosis. Additionally, a drug activating an enzyme called HMGCS2 is currently in clinical trials to treat steatotic liver disease.

Another promising target is a transcription factor called SOX4, which is normally only active during fetal development and shouldn't be active in adult liver tissue. When the researchers analyzed human liver tissue samples from patients at different disease stages, they found the same pattern seen in mice: normal liver function genes decreased over time while immature state genes increased.

The clinical implications are significant. Patients with higher expression of pro-cell-survival genes turned on by high-fat diets survived for less time after tumors developed. Additionally, patients with lower expression of genes supporting normal liver functions also had shorter survival times. This means doctors could potentially use gene expression patterns to predict patient outcomes and intervene earlier with targeted treatments.